Nature Genetics, ISSN 1061-4036, 05/2015, Volume 47, Issue 6, pp. 579 - 581
Primary familial brain calcification (PFBC) is a neurological disease characterized by calcium phosphate deposits in the basal ganglia and other brain regions...
DOMAIN-CONTAINING PROTEINS | HOMEOSTASIS | TRANSPORT | CELL-SURFACE RECEPTOR | GENE | BASAL GANGLIA CALCIFICATION | GENETICS & HEREDITY | RETROVIRUS | MURINE LEUKEMIA VIRUSES | MICE | Calcinosis - genetics | Genetic Predisposition to Disease | Genetic Association Studies | Humans | Middle Aged | Male | Neurodegenerative Diseases - genetics | Mutation, Missense | Receptors, Virus - genetics | Lod Score | DNA Mutational Analysis | Pedigree | HEK293 Cells | Female | Receptors, G-Protein-Coupled - genetics | Brain Diseases, Metabolic, Inborn - genetics | Development and progression | Nervous system diseases | Genetic aspects | Gene mutations | Health aspects | Flow cytometry | Stroke | Genealogy | Medical imaging | Womens health | Calcification | Ligands | Mutation | Calcium phosphates | Life Sciences | Human health and pathology | Neurons and Cognition | Neurobiology | Genetics | Endocrinology and metabolism | Human genetics
DOMAIN-CONTAINING PROTEINS | HOMEOSTASIS | TRANSPORT | CELL-SURFACE RECEPTOR | GENE | BASAL GANGLIA CALCIFICATION | GENETICS & HEREDITY | RETROVIRUS | MURINE LEUKEMIA VIRUSES | MICE | Calcinosis - genetics | Genetic Predisposition to Disease | Genetic Association Studies | Humans | Middle Aged | Male | Neurodegenerative Diseases - genetics | Mutation, Missense | Receptors, Virus - genetics | Lod Score | DNA Mutational Analysis | Pedigree | HEK293 Cells | Female | Receptors, G-Protein-Coupled - genetics | Brain Diseases, Metabolic, Inborn - genetics | Development and progression | Nervous system diseases | Genetic aspects | Gene mutations | Health aspects | Flow cytometry | Stroke | Genealogy | Medical imaging | Womens health | Calcification | Ligands | Mutation | Calcium phosphates | Life Sciences | Human health and pathology | Neurons and Cognition | Neurobiology | Genetics | Endocrinology and metabolism | Human genetics
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 11/2017, Volume 59, pp. 220.e1 - 220.e9
We performed whole-exome and whole-genome sequencing in 927 late-onset Alzheimer disease (LOAD) cases, 852 early-onset AD (EOAD) cases, and 1273 controls from...
ABCA7 | TREM2 | SORL1 | Alzheimer's disease | COMMON VARIANTS | DIAGNOSIS | DEMENTIA | OF-FUNCTION VARIANTS | NEUROSCIENCES | PLD3 | GERIATRICS & GERONTOLOGY | IDENTIFIES VARIANTS | DATABASE | MUTATION | PROGRAM | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Apolipoprotein E4 - genetics | Genetic Association Studies | Humans | Middle Aged | Male | LDL-Receptor Related Proteins - genetics | Membrane Glycoproteins - genetics | Whole Genome Sequencing | Young Adult | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Aged, 80 and over | Adult | Female | Aged | Genetic Variation - genetics | Alzheimer Disease - genetics | Receptors, Immunologic - genetics | Genomics | Risk factors
ABCA7 | TREM2 | SORL1 | Alzheimer's disease | COMMON VARIANTS | DIAGNOSIS | DEMENTIA | OF-FUNCTION VARIANTS | NEUROSCIENCES | PLD3 | GERIATRICS & GERONTOLOGY | IDENTIFIES VARIANTS | DATABASE | MUTATION | PROGRAM | GENOME-WIDE ASSOCIATION | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Apolipoprotein E4 - genetics | Genetic Association Studies | Humans | Middle Aged | Male | LDL-Receptor Related Proteins - genetics | Membrane Glycoproteins - genetics | Whole Genome Sequencing | Young Adult | ATP-Binding Cassette Transporters - genetics | Membrane Transport Proteins - genetics | Aged, 80 and over | Adult | Female | Aged | Genetic Variation - genetics | Alzheimer Disease - genetics | Receptors, Immunologic - genetics | Genomics | Risk factors
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0155940
Context Previous studies suggested that many patients, who have given their informed consent to participate in randomized controlled trials (RCT), have...
SURGERY | RANDOMIZED CONTROLLED-TRIALS | RECRUITMENT | EXPERIENCES | INTERVENTIONS | EMPATHY | MULTIDISCIPLINARY SCIENCES | DISEASE | CANCER | ANALGESIA | ETHICS | Health Personnel - standards | Randomized Controlled Trials as Topic - psychology | Humans | Health Personnel - psychology | Physician-Patient Relations | Parkinson Disease - drug therapy | Health Knowledge, Attitudes, Practice | Informed Consent - psychology | Randomized Controlled Trials as Topic - standards | Placebos | Informed Consent - standards | Patients - psychology | Huntington Disease - drug therapy | Medical personnel | Services | Usage | Clinical trials | Informed consent (Medical law) | Research | Methods | Medical research | Health | Physicians | Medical services | Parents | Systematic review | Patients | Placebo effect | Studies | Narratives | Informed consent | Children
SURGERY | RANDOMIZED CONTROLLED-TRIALS | RECRUITMENT | EXPERIENCES | INTERVENTIONS | EMPATHY | MULTIDISCIPLINARY SCIENCES | DISEASE | CANCER | ANALGESIA | ETHICS | Health Personnel - standards | Randomized Controlled Trials as Topic - psychology | Humans | Health Personnel - psychology | Physician-Patient Relations | Parkinson Disease - drug therapy | Health Knowledge, Attitudes, Practice | Informed Consent - psychology | Randomized Controlled Trials as Topic - standards | Placebos | Informed Consent - standards | Patients - psychology | Huntington Disease - drug therapy | Medical personnel | Services | Usage | Clinical trials | Informed consent (Medical law) | Research | Methods | Medical research | Health | Physicians | Medical services | Parents | Systematic review | Patients | Placebo effect | Studies | Narratives | Informed consent | Children
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 03/2016, Volume 98, Issue 3, pp. 500 - 513
Autosomal-recessive early-onset parkinsonism is clinically and genetically heterogeneous. The genetic causes of approximately 50% of autosomal-recessive...
Parkinsonism | Physiological aspects | Genetic aspects | Mitochondrial diseases | Gene mutations | Health aspects | Life Sciences | Neurons and Cognition
Parkinsonism | Physiological aspects | Genetic aspects | Mitochondrial diseases | Gene mutations | Health aspects | Life Sciences | Neurons and Cognition
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 07/2019, Volume 79, pp. 22 - 29
It is currently unknown whether brain atrophy subtypes defined in Alzheimer's disease are clinically relevant during aging. We investigated participants (n =...
Aging | Alzheimer | Imaging | Cohort study | Hippocampus | Cortex | DEMENTIA | DEFINED SUBTYPES | MRI | VOLUME | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | DISEASE | SEGMENTATION | NEUROPATHOLOGY | Medicine, Experimental | Brain | Medical research | Neurosciences | Aged | Alzheimer's disease | Computer Science | Medical Imaging
Aging | Alzheimer | Imaging | Cohort study | Hippocampus | Cortex | DEMENTIA | DEFINED SUBTYPES | MRI | VOLUME | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | DISEASE | SEGMENTATION | NEUROPATHOLOGY | Medicine, Experimental | Brain | Medical research | Neurosciences | Aged | Alzheimer's disease | Computer Science | Medical Imaging
Journal Article
JAMA Neurology, ISSN 2168-6149, 07/2017, Volume 74, Issue 7, pp. 780 - 792
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standing observations of an association between immune-mediated...
Clinical Neurology | COMMON VARIANTS | RISK LOCI | ACTIVATION | MULTIPLE-SCLEROSIS | INFLAMMATION | MECHANISMS | ASSOCIATION | EXPRESSION | MYOTONIC-DYSTROPHY | IDENTIFIES 7 | CLINICAL NEUROLOGY | Crohn Disease - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Celiac Disease - genetics | Humans | Risk Factors | Colitis, Ulcerative - genetics | Diabetes Mellitus, Type 1 - genetics | Multiple Sclerosis - genetics | Genetic Pleiotropy | Genetic Loci | Parkinson Disease - genetics | Autoimmune Diseases - genetics | Arthritis, Rheumatoid - genetics | Psoriasis - genetics | Online First | Original Investigation | Research
Clinical Neurology | COMMON VARIANTS | RISK LOCI | ACTIVATION | MULTIPLE-SCLEROSIS | INFLAMMATION | MECHANISMS | ASSOCIATION | EXPRESSION | MYOTONIC-DYSTROPHY | IDENTIFIES 7 | CLINICAL NEUROLOGY | Crohn Disease - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Celiac Disease - genetics | Humans | Risk Factors | Colitis, Ulcerative - genetics | Diabetes Mellitus, Type 1 - genetics | Multiple Sclerosis - genetics | Genetic Pleiotropy | Genetic Loci | Parkinson Disease - genetics | Autoimmune Diseases - genetics | Arthritis, Rheumatoid - genetics | Psoriasis - genetics | Online First | Original Investigation | Research
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 02/2017, Volume 65, Issue 2, pp. 415 - 420
Objectives To determine the prevalence of dementia and cognitive impairment in older people across generations. Design Two prospective cohort studies...
cohort studies | dementia | prevalence studies | cognitive disorders | POPULATION | DIAGNOSIS | ALZHEIMERS-DISEASE | ADULTS | COGNITIVE IMPAIRMENT | HYPERCHOLESTEROLEMIA | GERIATRICS & GERONTOLOGY | OBESITY | COMMUNITY | GERONTOLOGY | HYPERTENSION | PROGRAM | France - epidemiology | Prevalence | Humans | Proportional Hazards Models | Farmers - statistics & numerical data | Male | Dementia - epidemiology | Neuropsychological Tests | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Female | Aged | Cohort Studies | Farmers | Epidemiology | Dementia | Geriatrics
cohort studies | dementia | prevalence studies | cognitive disorders | POPULATION | DIAGNOSIS | ALZHEIMERS-DISEASE | ADULTS | COGNITIVE IMPAIRMENT | HYPERCHOLESTEROLEMIA | GERIATRICS & GERONTOLOGY | OBESITY | COMMUNITY | GERONTOLOGY | HYPERTENSION | PROGRAM | France - epidemiology | Prevalence | Humans | Proportional Hazards Models | Farmers - statistics & numerical data | Male | Dementia - epidemiology | Neuropsychological Tests | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Female | Aged | Cohort Studies | Farmers | Epidemiology | Dementia | Geriatrics
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9766, pp. 641 - 649
Summary Background Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci ( MAPT and SNCA ) to risk of Parkinson's disease. We...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SUSCEPTIBILITY | SYNAPTOTAGMIN-XI | STK39 | COMMON | LOCI | MUTATIONS | SUGGESTS | REGION | SNCA | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Risk Assessment | Humans | Middle Aged | Genetic Loci - genetics | Genotype | Male | Parkinson Disease - genetics | Age of Onset | Alleles | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genetic Variation - genetics | Sequence Analysis | Genetic aspects | Parkinson's disease | Research | Genetic variation | Risk factors | Studies | DNA methylation | Medical research | Genetics | Parkinsons disease
Internal Medicine | MEDICINE, GENERAL & INTERNAL | SUSCEPTIBILITY | SYNAPTOTAGMIN-XI | STK39 | COMMON | LOCI | MUTATIONS | SUGGESTS | REGION | SNCA | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Risk Assessment | Humans | Middle Aged | Genetic Loci - genetics | Genotype | Male | Parkinson Disease - genetics | Age of Onset | Alleles | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genetic Variation - genetics | Sequence Analysis | Genetic aspects | Parkinson's disease | Research | Genetic variation | Risk factors | Studies | DNA methylation | Medical research | Genetics | Parkinsons disease
Journal Article
9.
Full Text
Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
Neurology, ISSN 0028-3878, 01/2014, Volume 82, Issue 4, pp. 300 - 307
OBJECTIVE:The AMANDYSK trial was designed to assess long-term efficacy of chronic treatment with amantadine in patients with Parkinson disease (PD) and...
MOTOR FLUCTUATIONS | SARIZOTAN | MULTIPLE-SCLEROSIS | LEVODOPA-INDUCED DYSKINESIAS | FATIGUE | DOUBLE-BLIND | COMPLICATIONS | QUALITY-OF-LIFE | SCALE | DURATION | CLINICAL NEUROLOGY | Severity of Illness Index | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Amantadine - therapeutic use | Antiparkinson Agents - therapeutic use | Dyskinesia, Drug-Induced - drug therapy | Levodopa - adverse effects | Female | Aged
MOTOR FLUCTUATIONS | SARIZOTAN | MULTIPLE-SCLEROSIS | LEVODOPA-INDUCED DYSKINESIAS | FATIGUE | DOUBLE-BLIND | COMPLICATIONS | QUALITY-OF-LIFE | SCALE | DURATION | CLINICAL NEUROLOGY | Severity of Illness Index | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Amantadine - therapeutic use | Antiparkinson Agents - therapeutic use | Dyskinesia, Drug-Induced - drug therapy | Levodopa - adverse effects | Female | Aged
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 3, pp. 264 - 274
Summary Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative movement disorder that is characterised by autonomic...
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Neurology | DIAGNOSIS | GROUP EMSA-SG | NUCLEUS | DISORDERS | SYMPTOMS | PATIENT | QUALITY-OF-LIFE | DEEP BRAIN-STIMULATION | CLINICAL NEUROLOGY | PROGRESSIVE SUPRANUCLEAR PALSY | PARKINSONS-DISEASE | Severity of Illness Index | Prospective Studies | Europe | Humans | Middle Aged | Male | Parkinson Disease - physiopathology | Autonomic Nervous System Diseases - diagnosis | Disease Progression | Autonomic Nervous System Diseases - mortality | Cerebellar Ataxia - physiopathology | Phenotype | Autonomic Nervous System Diseases - physiopathology | Parkinson Disease - diagnosis | Multiple System Atrophy - mortality | Aged | Multiple System Atrophy - classification | Multiple System Atrophy - diagnosis | Multiple System Atrophy - physiopathology | Cerebellar Ataxia - diagnosis | Cerebellar Ataxia - mortality | Cohort Studies | Parkinson Disease - mortality | Atrophy | Medical colleges | Nervous system diseases | Neurosciences | Analysis | Neurologi | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article